-+ 0.00%
-+ 0.00%
-+ 0.00%

REGENERON PHARMACEUTICALS, - TO ADVANCE UBAMATAMAB INTO CONFIRMATORY PHASE 3 TRIAL FOR LGSOC

Reuters·10/01/2026 15:37:05